Privia Health Group, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On August 7, 2026, Parth Mehrotra, the Company’s Chief Executive Officer and a member of the Board, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Mehrotra Plan”). The first possible trade date under the New Mehrotra Plan is November 9, 2026, and the end date of the New Mehrotra Plan is August 4, 2028, for a duration of approximately 21 months. The aggregate amount of securities that may be sold under the New Mehrotra Plan is 1,229,423 shares of common stock.
On August 14, 2026, David Mountcastle, the Company’s Chief Financial Officer, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Mountcastle Plan”). The first possible trade date under the New Mountcastle Plan is November 13, 2026, and the end date of the New Mountcastle Plan is November 30, 2027, for a duration of approximately one year. The aggregate amount of securities that may be sold under the New Mountcastle Plan is 181,230 shares of common stock.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.